
Joinn Laboratories(China)Co.,Ltd.
SSE:603127.SS
19.8 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||
Net Income
| 69.755 | 391.553 | 1,073.2 | 556.416 | 313.628 | 178.212 | 108.187 | 76.446 | 51.693 | 49.175 | 48.997 | 22.288 | 9.626 |
Depreciation & Amortization
| 130.32 | 129.512 | 120.96 | 96.438 | 60.651 | 42.365 | 29.055 | 26.195 | 27.098 | 23.864 | 20.536 | 14.937 | 12.728 |
Deferred Income Tax
| 0 | -21.812 | 5.23 | -171.73 | -61.376 | -2.214 | -0.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 6.028 | 9.588 | 23.513 | 29.906 | 11.653 | 8.274 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 40.593 | -126.836 | 181.921 | 158.756 | 86.334 | -84.142 | 51.17 | 22.73 | 44.017 | 36.751 | 13.06 | 0 | 0 |
Accounts Receivables
| -5.146 | -91.413 | -127.685 | -61.187 | -18.798 | -61.424 | -29.763 | -10.808 | -9.394 | 6.324 | -8.654 | 0 | 0 |
Inventory
| 384.196 | 239.358 | -182.456 | -226.741 | -139.969 | -65.31 | -23.79 | -30.281 | -14.947 | -14.8 | -2.145 | 0 | 0 |
Accounts Payables
| 0 | -252.969 | 486.832 | -6.642 | 244.392 | 45.981 | 105.382 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| -338.456 | -21.812 | 5.23 | 453.326 | 0.709 | -3.388 | 74.96 | 53.011 | 58.965 | 51.551 | 15.205 | 0 | 0 |
Other Non Cash Items
| 98.261 | 269.281 | -419.833 | 22.262 | -0.757 | 2.218 | -12.336 | -5.365 | -3.986 | -3.564 | -0.217 | -22.288 | -9.626 |
Operating Cash Flow
| 338.929 | 647.726 | 971.066 | 685.655 | 428.386 | 148.092 | 176.076 | 120.006 | 118.822 | 106.225 | 82.376 | 60.907 | 20.332 |
Investing Activities: | |||||||||||||
Investments In Property Plant And Equipment
| -269.391 | -192.721 | -274.841 | -237.245 | -148.978 | -126.776 | -129.923 | -25.321 | -52.425 | -43.206 | -38.89 | -52.256 | -57.768 |
Acquisitions Net
| 0 | -89.909 | -1,689.055 | 10.247 | 0.186 | -192.244 | 129.923 | 25.45 | 0 | 0.042 | 0.049 | 0 | 0 |
Purchases Of Investments
| -5,059.135 | -647.352 | -1,090.196 | -2,622.117 | -444 | -1,209.4 | -773.968 | -372 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 3,355.734 | 606.348 | 907.403 | 789.308 | 341.535 | 1,426.317 | 634.363 | 173.521 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 9.768 | -16.646 | -13.442 | -10 | -3.646 | 0.013 | -129.923 | -25.321 | -52.425 | -1.318 | -3.579 | 34.465 | -0.344 |
Investing Cash Flow
| -1,963.024 | -340.28 | -2,160.131 | -2,069.807 | -254.903 | -102.091 | -269.528 | -223.671 | -52.425 | -44.524 | -42.468 | -17.791 | -58.112 |
Financing Activities: | |||||||||||||
Debt Repayment
| 0 | -6.895 | -3.425 | -3.723 | 3.842 | -0.728 | 0 | 0 | 0 | -49 | -14 | -55.1 | -51.9 |
Common Stock Issued
| 0 | 0 | 0 | 5,402.46 | 0 | 0 | -0.2 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | -113.582 | -23.787 | -0.655 | 0 | -0.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -119.633 | -214.244 | -137.364 | -94.85 | -55.051 | -34.49 | -24.642 | -0.021 | -0.009 | -3.599 | -13.642 | -5.888 | -8.745 |
Other Financing Activities
| -145.994 | -26.957 | 65.243 | -12.83 | 14.336 | 19.811 | 9.35 | 224.218 | 2.337 | 3.086 | 12.542 | 3.383 | 88.708 |
Financing Cash Flow
| -265.627 | -361.678 | -99.332 | 5,290.402 | -36.874 | -15.407 | -15.292 | 227.127 | 2.328 | -49.513 | -15.101 | -57.605 | 28.063 |
Other Information: | |||||||||||||
Effect Of Forex Changes On Cash
| 1.279 | 8.41 | 37.47 | -60.898 | -8.523 | -2.329 | 2.819 | -1.545 | 0.713 | 0.192 | -0.073 | -0.492 | -0.116 |
Net Change In Cash
| -1,888.444 | -45.823 | -1,250.927 | 3,845.352 | 128.086 | 28.265 | -105.925 | 121.918 | 69.438 | 12.38 | 24.733 | -14.981 | -9.833 |
Cash At End Of Period
| 965.203 | 2,853.647 | 2,899.47 | 4,150.396 | 305.044 | 176.958 | 148.693 | 254.617 | 132.699 | 63.261 | 50.881 | 26.147 | 41.128 |